Bank of Montreal Can Buys 10,326 Shares of Humana Inc. (NYSE:HUM)

Bank of Montreal Can grew its stake in shares of Humana Inc. (NYSE:HUM) by 6.9% during the 2nd quarter, Holdings Channel.com reports. The firm owned 159,708 shares of the insurance provider’s stock after buying an additional 10,326 shares during the quarter. Bank of Montreal Can’s holdings in Humana were worth $59,699,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Evergreen Capital Management LLC acquired a new position in Humana during the 2nd quarter worth approximately $328,000. Integral Health Asset Management LLC increased its holdings in shares of Humana by 25.0% during the second quarter. Integral Health Asset Management LLC now owns 75,000 shares of the insurance provider’s stock valued at $28,024,000 after acquiring an additional 15,000 shares in the last quarter. Public Sector Pension Investment Board raised its position in shares of Humana by 71.5% during the second quarter. Public Sector Pension Investment Board now owns 4,622 shares of the insurance provider’s stock worth $1,727,000 after purchasing an additional 1,927 shares during the period. EverSource Wealth Advisors LLC raised its position in shares of Humana by 25.8% during the second quarter. EverSource Wealth Advisors LLC now owns 375 shares of the insurance provider’s stock worth $136,000 after purchasing an additional 77 shares during the period. Finally, Fidelis Capital Partners LLC raised its position in shares of Humana by 7.8% during the second quarter. Fidelis Capital Partners LLC now owns 981 shares of the insurance provider’s stock worth $339,000 after purchasing an additional 71 shares during the period. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HUM. TD Cowen upped their price objective on shares of Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a report on Wednesday, July 24th. JPMorgan Chase & Co. upped their target price on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. Truist Financial raised their price target on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a research report on Monday, July 15th. Morgan Stanley initiated coverage on Humana in a report on Monday, June 24th. They set an “equal weight” rating and a $374.00 price objective for the company. Finally, Robert W. Baird began coverage on Humana in a report on Thursday, May 30th. They issued a “neutral” rating and a $374.00 target price on the stock. Thirteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $398.70.

Humana Trading Down 0.1 %

NYSE:HUM opened at $311.95 on Thursday. The firm’s 50 day moving average is $354.61 and its 200 day moving average is $345.12. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The stock has a market capitalization of $37.56 billion, a PE ratio of 19.42, a price-to-earnings-growth ratio of 2.44 and a beta of 0.50. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The firm had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter in the prior year, the firm earned $8.94 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. Sell-side analysts expect that Humana Inc. will post 16.01 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 annualized dividend and a dividend yield of 1.13%. Humana’s payout ratio is 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.